ATE359772T1 - Endothelin-niveau senkende mittel - Google Patents

Endothelin-niveau senkende mittel

Info

Publication number: ATE359772T1
Authority: AT; Austria
Prior art keywords: lowering agents; level lowering; endothelin; endothelin level; mammals
Prior art date: 1998-12-09

Application number

AT99959457T

Other languages

English (en)

Inventor

Olavi Ylikorkala

Merja Metsae-Heikkilae

Paeivi Hietanen

Juha Ellmen

Original Assignee

Orion Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-09

Filing date

1999-12-08

Publication date

2007-05-15

1999-12-08 Application filed by Orion Corp filed Critical Orion Corp

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE359772T1 publication Critical patent/ATE359772T1/de

Links

102000002045 Endothelin Human genes 0.000 title abstract 2
108050009340 Endothelin Proteins 0.000 title abstract 2
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title abstract 2
102100033902 Endothelin-1 Human genes 0.000 abstract 1
101800004490 Endothelin-1 Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
MKYQPGPNVYRMHI-UHFFFAOYSA-N Triphenylethylene Chemical group C=1C=CC=CC=1C=C(C=1C=CC=CC=1)C1=CC=CC=C1 MKYQPGPNVYRMHI-UHFFFAOYSA-N 0.000 abstract 1
229940046836 anti-estrogen Drugs 0.000 abstract 1
230000001833 anti-estrogenic effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000000328 estrogen antagonist Substances 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
229960005026 toremifene Drugs 0.000 abstract 1
XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT99959457T 1998-12-09 1999-12-08 Endothelin-niveau senkende mittel ATE359772T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9827121.6A GB9827121D0 (en)	1998-12-09	1998-12-09	Agent for lowering endothelin levels

Publications (1)

Publication Number	Publication Date
ATE359772T1 true ATE359772T1 (de)	2007-05-15

Family

ID=10843940

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99959457T ATE359772T1 (de)	1998-12-09	1999-12-08	Endothelin-niveau senkende mittel

Country Status (11)

Country	Link
US (1)	US6569904B1 (de)
EP (1)	EP1137408B1 (de)
JP (1)	JP4563587B2 (de)
AT (1)	ATE359772T1 (de)
AU (1)	AU1662300A (de)
CA (1)	CA2353808C (de)
DE (1)	DE69935865T2 (de)
DK (1)	DK1137408T3 (de)
ES (1)	ES2284276T3 (de)
GB (1)	GB9827121D0 (de)
WO (1)	WO2000033828A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030032676A1 (en) *	2001-08-09	2003-02-13	Kimelberg Harold K.	Drugs for treatment of cerebral injury and methods of use thereof
TW200740442A (en)	2005-08-29	2007-11-01	Taiho Pharmaceutical Co Ltd	Therapeutic agent for hypertension
US20110118355A1 (en) *	2007-09-21	2011-05-19	Harry Fisch	Treatment of migraine headaches using antiestrogens
WO2009052377A1 (en) *	2007-10-18	2009-04-23	Harry Fisch	Treatment of migraine headaches using antiestrogens
JP5642937B2 (ja) *	2009-03-09	2014-12-17	花王株式会社	エンドセリン発現抑制剤の評価又は選択方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5770609A (en) *	1993-01-28	1998-06-23	Neorx Corporation	Prevention and treatment of cardiovascular pathologies
US5595722A (en) *	1993-01-28	1997-01-21	Neorx Corporation	Method for identifying an agent which increases TGF-beta levels
JPH11510479A (ja) *	1995-06-07	1999-09-14	ネオルックスコーポレイション	タモキシフェン類似体による心臓血管疾病の予防及び治療
AR008155A1 (es) *	1996-09-06	1999-12-09	Smithkline Beecham Corp	Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
US6069175A (en) *	1996-11-15	2000-05-30	Pfizer Inc.	Estrogen agonist/antagonists treatment of atherosclerosis

1998
- 1998-12-09 GB GBGB9827121.6A patent/GB9827121D0/en not_active Ceased
1999
- 1999-12-08 AT AT99959457T patent/ATE359772T1/de active
- 1999-12-08 DE DE69935865T patent/DE69935865T2/de not_active Expired - Lifetime
- 1999-12-08 JP JP2000586321A patent/JP4563587B2/ja not_active Expired - Fee Related
- 1999-12-08 WO PCT/FI1999/001016 patent/WO2000033828A1/en not_active Ceased
- 1999-12-08 ES ES99959457T patent/ES2284276T3/es not_active Expired - Lifetime
- 1999-12-08 US US09/857,560 patent/US6569904B1/en not_active Expired - Fee Related
- 1999-12-08 CA CA002353808A patent/CA2353808C/en not_active Expired - Fee Related
- 1999-12-08 DK DK99959457T patent/DK1137408T3/da active
- 1999-12-08 AU AU16623/00A patent/AU1662300A/en not_active Abandoned
- 1999-12-08 EP EP99959457A patent/EP1137408B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU1662300A (en)	2000-06-26
US6569904B1 (en)	2003-05-27
DK1137408T3 (da)	2007-07-30
EP1137408B1 (de)	2007-04-18
DE69935865D1 (de)	2007-05-31
WO2000033828A1 (en)	2000-06-15
JP2002531496A (ja)	2002-09-24
JP4563587B2 (ja)	2010-10-13
CA2353808C (en)	2008-08-05
ES2284276T3 (es)	2007-11-01
GB9827121D0 (en)	1999-02-03
DE69935865T2 (de)	2007-12-20
CA2353808A1 (en)	2000-06-15
EP1137408A1 (de)	2001-10-04

Legal Events

Date

Code

Title

Description

2007-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1137408

Country of ref document: EP

Publication	Publication Date	Title
SE9702860D0 (sv)	1997-08-05	New use
BR0107565A (pt)	2003-02-11	Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
DK1503788T3 (da)	2011-10-17	Behandling af alpha-galactosidase A-deficiens
HUP0203529A2 (hu)	2003-02-28	Dezloratadin alkalmazása alvászavarok kezelésére
UA70925C2 (uk)	2004-11-15	Спосіб лікування естрогенстимульованого раку
DE69932510D1 (de)	2006-09-07	Vaskularisierungsinhibitoren
CY1109191T1 (el)	2014-07-02	Μια νεα χρηση της δεφεριπρονης
EA200401341A1 (ru)	2005-06-30	Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
DK0998287T3 (da)	2003-09-01	Anvendelse af levobupivacain
EA200300560A1 (ru)	2003-10-30	Улучшенный способ лечения
DE50101034D1 (de)	2004-01-08	Medizinischer oder dentalmedizinischer behandlungsstuhl
NO20004419L (no)	2000-10-20	Ny anvendelse
BRPI0408491A (pt)	2006-04-04	tratamento da doença de alzheimer
DK0981347T3 (da)	2003-09-15	Anvendelsen af levobupivacain i ansigtkirurgi
DE69935853D1 (de)	2007-05-31	Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten
BR9814214A (pt)	2000-10-03	Composição com ácido azeláico
EA200501528A1 (ru)	2006-04-28	Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний
MXPA05001885A (es)	2005-06-03	El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
BR0107960A (pt)	2002-10-29	Tratamento de condições alérgicas e inflamatórias
DE69935865D1 (de)	2007-05-31	Endothelin-niveau senkende mittel
PT888114E (pt)	2002-11-29	Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil\|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
TR200200278T2 (tr)	2002-06-21	Kalsilitik bileşimler
EE200300213A (et)	2003-08-15	SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
ATE297732T1 (de)	2005-07-15	Kombinationstherapie zur behandlung von herzinsuffizienz
BR0000486A (pt)	2001-08-21	Antagonistas do neuropeptìdeo y